To compare argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure: mid-term results.
Lai J S M, Tham C C Y, Chua J K H, Poon A S Y, Chan J C H, Lam S W, Lam D S C
AI Summary
This study found no significant difference in final IOP or medication need between ALPI and systemic drugs for acute angle-closure, suggesting comparable mid-term efficacy.
Abstract
Purpose
To compare the clinical outcome of argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure (APAC).
Methods
Consecutive patients with APAC were recruited and randomized to receive one of two treatment options: immediate ALPI or systemic acetazolamide +/- mannitol. All eyes were followed up for at least 6 months after laser iridotomy. Main outcome measures were intraocular pressure (IOP) and requirement for glaucoma medications.
Results
A total of 41 eyes (39 patients) were randomized into the ALPI group, and 38 eyes (32 patients) into the medical treatment group. There were no significant differences between the two groups in sex, age, presenting IOP, and duration of attack. Mean follow-up duration +/- SD was 15.7 +/- 5.8 months. There were no significant differences between the two groups in mean final IOP and requirement for glaucoma medications.
Conclusions
There were no statistically significant differences in mean IOP and requirement for glaucoma drugs between APAC eyes treated with ALPI and systemic medications.
MeSH Terms
Shields Classification
Related Articles5
Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma : a prospective, randomized, controlled trial.
Randomized Controlled TrialArgon Laser Peripheral Iridoplasty for Primary Angle-Closure Glaucoma: A Randomized Controlled Trial.
Randomized Controlled TrialAnterior segment morphology after acute primary angle closure treatment: a randomised study comparing iridoplasty and medical therapy.
Randomized Controlled TrialTreatment of the fellow eye in acute angle-closure glaucoma: a case report and survey of members of the American Glaucoma Society.
Case ReportImmediate argon laser peripheral iridoplasty as treatment for acute attack of primary angle-closure glaucoma: a preliminary study.
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.